Dendritic cells
Dendritic cells is a biological therapy with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Treatment of Recurrent Bladder Cancer With Dendritic Cells
Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults
Immunogenicity and Safety of DCs in Breast Cancer
Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
Safety and Efficacy of IDH1R132H-DC Vaccine in Gliomas
Clinical Trials (6)
Treatment of Recurrent Bladder Cancer With Dendritic Cells
Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults
Immunogenicity and Safety of DCs in Breast Cancer
Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
Safety and Efficacy of IDH1R132H-DC Vaccine in Gliomas
Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients
All 6 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 6